Biliary tract: Therapeutic strategies for cholangiocarcinoma-wishing on WNT inhibitors?
Katrina
K
Ray
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D044482:Benzeneacetamides / Q000494:pharmacology*; D001650:Bile Duct Neoplasms / Q000378:metabolism*; D001653:Bile Ducts, Intrahepatic / Q000378:metabolism*; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000494:pharmacology*; D018281:Cholangiocarcinoma / Q000378:metabolism*; D006801:Humans; D008297:Male; D011725:Pyridines / Q000494:pharmacology*; D011744:Pyrimidinones / Q000494:pharmacology*; D060449:Wnt Signaling Pathway
D000970:Antineoplastic Agents; D044482:Benzeneacetamides; D019086:Bridged Bicyclo Compounds, Heterocyclic; D011725:Pyridines; D011744:Pyrimidinones